0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-37.92%
Negative revenue growth while 9698.HK stands at 8.74%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-32.44%
Negative gross profit growth while 9698.HK is at 10.63%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
39.12%
Operating income growth above 1.5x 9698.HK's 25.07%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
9.82%
Positive net income growth while 9698.HK is negative. John Neff might see a big relative performance advantage.
8.00%
EPS growth of 8.00% while 9698.HK is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
8.00%
Diluted EPS growth of 8.00% while 9698.HK is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
1.70%
Share count expansion well above 9698.HK's 0.25%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.70%
Diluted share count expanding well above 9698.HK's 0.25%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
99.28%
OCF growth at 50-75% of 9698.HK's 197.30%. Martin Whitman would question if the firm lags in monetizing sales effectively.
99.97%
Positive FCF growth while 9698.HK is negative. John Neff would see a strong competitive edge in net cash generation.
-11.98%
Negative 10Y revenue/share CAGR while 9698.HK stands at 398.61%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-68.68%
Negative 5Y CAGR while 9698.HK stands at 398.61%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-55.35%
Negative 3Y CAGR while 9698.HK stands at 398.61%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
2680.63%
10Y OCF/share CAGR above 1.5x 9698.HK's 541.97%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
405.48%
5Y OCF/share CAGR at 50-75% of 9698.HK's 541.97%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
49.13%
3Y OCF/share CAGR under 50% of 9698.HK's 541.97%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-49.61%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-59.07%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
552.73%
Positive short-term CAGR while 9698.HK is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
1.59%
Below 50% of 9698.HK's 237.75%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-4.84%
Negative 3Y equity/share growth while 9698.HK is at 237.75%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while 9698.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-42.29%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-58.41%
Inventory is declining while 9698.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-8.31%
Negative asset growth while 9698.HK invests at 3.31%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.18%
Positive BV/share change while 9698.HK is negative. John Neff sees a clear edge over a competitor losing equity.
-78.21%
We’re deleveraging while 9698.HK stands at 3.95%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-1.73%
We cut SG&A while 9698.HK invests at 3.66%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.